Syngene International Limited Bombay S.E.
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
700.2 INR | +0.17% | -1.75% | -0.04% |
Apr. 25 | Transcript : Syngene International Limited, Q4 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Syngene International Limited Recommends Final Dividend for the Financial Year 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- SYNGENE Stock
- SYNGENE Stock
- News Syngene International Limited
- Syngene International : Consolidated Net Profit Climbs in Fiscal Q1